Paul K. Audhya Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity

KALV Quotes by TradingView

Paul K. Audhya is CHIEF MEDICAL OFFICER of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 97,012 shares of KALV, which is worth approximately $849,825. The most recent transaction as insider was on Nov 26, 2024, when has been sold 2,187 shares (Common Stock) at a price of $9.87 per share, resulting in proceeds of $21,585. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 97K
15.84% 3M change
165.29% 12M change
Total Value Held $849,825

Paul K. Audhya Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 26 2024
SELL
Open market or private sale
$21,585 $9.87 p/Share
2,187 Reduced 2.2%
97,012 Common Stock
Nov 22 2024
BUY
Exercise of conversion of derivative security
-
5,000 Added 4.8%
99,199 Common Stock
Nov 18 2024
SELL
Open market or private sale
$74,793 $9.26 p/Share
8,077 Reduced 7.9%
94,199 Common Stock
Nov 17 2024
BUY
Exercise of conversion of derivative security
-
18,531 Added 15.34%
102,276 Common Stock
Aug 23 2024
SELL
Open market or private sale
$26,474 $12.4 p/Share
2,135 Reduced 2.49%
83,745 Common Stock
Aug 22 2024
BUY
Exercise of conversion of derivative security
-
5,000 Added 5.5%
85,880 Common Stock
Aug 19 2024
SELL
Open market or private sale
$95,755 $12.01 p/Share
7,973 Reduced 8.97%
80,880 Common Stock
Aug 17 2024
BUY
Exercise of conversion of derivative security
-
18,528 Added 17.25%
88,853 Common Stock
May 20 2024
SELL
Open market or private sale
$154,938 $11.76 p/Share
13,175 Reduced 15.78%
70,325 Common Stock
May 17 2024
BUY
Exercise of conversion of derivative security
-
30,614 Added 26.83%
83,500 Common Stock
Feb 20 2024
SELL
Open market or private sale
$201,845 $14.12 p/Share
14,295 Reduced 21.28%
52,886 Common Stock
Feb 17 2024
BUY
Exercise of conversion of derivative security
-
30,613 Added 31.3%
67,181 Common Stock
Nov 20 2023
SELL
Open market or private sale
$65,716 $8.23 p/Share
7,985 Reduced 17.92%
36,568 Common Stock
Nov 17 2023
BUY
Exercise of conversion of derivative security
-
18,530 Added 29.37%
44,553 Common Stock
Aug 18 2023
SELL
Open market or private sale
$86,054 $10.73 p/Share
8,020 Reduced 23.56%
26,023 Common Stock
Aug 17 2023
BUY
Exercise of conversion of derivative security
-
18,529 Added 35.24%
34,043 Common Stock
May 18 2023
SELL
Open market or private sale
$28,189 $10.14 p/Share
2,780 Reduced 17.6%
13,014 Common Stock
May 17 2023
BUY
Exercise of conversion of derivative security
-
6,447 Added 28.99%
15,794 Common Stock
Feb 17 2023
SELL
Open market or private sale
$26,135 $7.66 p/Share
3,412 Reduced 26.74%
9,347 Common Stock
Feb 17 2023
BUY
Exercise of conversion of derivative security
-
6,446 Added 50.52%
6,313 Common Stock
Nov 18 2022
SELL
Open market or private sale
$3,927 $5.44 p/Share
722 Reduced 10.83%
5,946 Common Stock
Nov 17 2022
BUY
Exercise of conversion of derivative security
-
2,419 Added 26.62%
6,668 Common Stock
Aug 17 2022
SELL
Open market or private sale
$10,846 $14.96 p/Share
725 Reduced 29.98%
1,693 Common Stock
Aug 17 2022
BUY
Exercise of conversion of derivative security
-
2,418 Added 50.0%
2,418 Common Stock
PKA

Paul K. Audhya

CHIEF MEDICAL OFFICER
Cambridge, MA

Track Institutional and Insider Activities on KALV

Follow KalVista Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

News

Receive news related to KalVista Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KALV